Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
doi: 10.1046/j.1523-1755.2003.00712.x
The AWARD-7 (Dulaglutide vs insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease) trial evaluated the effects of dulaglutide, a GLP-1 receptor agonist, in patients with T2D and moderate-to-severe CKD
Eating smaller, more frequent meals and avoiding high-fat foods can help minimize discomfort
It can result in fewer wrinkles and fine lines and healthier, more youthful-looking skin
Persistent ER stress promotes the extensive release of Ca 2+ into the cytoplasm via the IP3R channel
Theory Biosci
US$ 27.35
US$ 22.47
US$ 29.06
US$ 24.68
US$ 27.08
US$ 23.83
